Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2020 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
jaime l k m[Author]
(4 results)?
OncoLoop: A Network-Based Precision Cancer Medicine Framework.
Cancer Discov. 2023 Feb 6;13(2):386-409. doi: 10.1158/2159-8290.CD-22-0342.
Cancer Discov. 2023.
PMID: 36374194
Free PMC article.
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.
Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, Picech F, Schäfer G, De Castro GJ, Hibshoosh H, Loda M, Klocker H, Rubin MA, Zheng T, Benson MC, McKiernan JM, Dutta A, Abate-Shen C.
Papachristodoulou A, et al. Among authors: kim jy.
Eur Urol. 2024 Apr;85(4):361-372. doi: 10.1016/j.eururo.2023.07.016. Epub 2023 Aug 31.
Eur Urol. 2024.
PMID: 37659962
Item in Clipboard
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.
Arriaga JM, Panja S, Alshalalfa M, Zhao J, Zou M, Giacobbe A, Madubata CJ, Kim JY, Rodriguez A, Coleman I, Virk RK, Hibshoosh H, Ertunc O, Ozbek B, Fountain J, Jeffrey Karnes R, Luo J, Antonarakis ES, Nelson PS, Feng FY, Rubin MA, De Marzo AM, Rabadan R, Sims PA, Mitrofanova A, Abate-Shen C.
Arriaga JM, et al.
Nat Cancer. 2020 Nov;1(11):1082-1096. doi: 10.1038/s43018-020-00125-0. Epub 2020 Oct 19.
Nat Cancer. 2020.
PMID: 34085047
Free PMC article.
Item in Clipboard
NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.
Papachristodoulou A, Rodriguez-Calero A, Panja S, Margolskee E, Virk RK, Milner TA, Martina LP, Kim JY, Di Bernardo M, Williams AB, Maliza EA, Caputo JM, Haas C, Wang V, De Castro GJ, Wenske S, Hibshoosh H, McKiernan JM, Shen MM, Rubin MA, Mitrofanova A, Dutta A, Abate-Shen C.
Papachristodoulou A, et al. Among authors: kim jy.
Cancer Discov. 2021 Sep;11(9):2316-2333. doi: 10.1158/2159-8290.CD-20-1765. Epub 2021 Apr 23.
Cancer Discov. 2021.
PMID: 33893149
Free PMC article.
Item in Clipboard
Cooperation of loss of NKX3.1 and inflammation in prostate cancer initiation.
Le Magnen C, Virk RK, Dutta A, Kim JY, Panja S, Lopez-Bujanda ZA, Califano A, Drake CG, Mitrofanova A, Abate-Shen C.
Le Magnen C, et al.
Dis Model Mech. 2018 Nov 16;11(11):dmm035139. doi: 10.1242/dmm.035139.
Dis Model Mech. 2018.
PMID: 30266798
Free PMC article.
Item in Clipboard
Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.
Park S, Rong L, Owczarek TB, Bernardo MD, Shoulson RL, Chua CW, Kim JY, Lankarani A, Chakrapani P, Syed T, McKiernan JM, Solit DB, Shen MM, Al-Ahmadie HA, Abate-Shen C.
Park S, et al. Among authors: kim jy.
Cancer Res. 2021 Oct 15;81(20):5161-5175. doi: 10.1158/0008-5472.CAN-21-1254. Epub 2021 Sep 1.
Cancer Res. 2021.
PMID: 34470779
Free PMC article.
Item in Clipboard
Co-clinical Analysis of a Genetically Engineered Mouse Model and Human Prostate Cancer Reveals Significance of NKX3.1 Expression for Response to 5α-reductase Inhibition.
Dutta A, Panja S, Virk RK, Kim JY, Zott R, Cremers S, Golombos DM, Liu D, Mosquera JM, Mostaghel EA, Barbieri CE, Mitrofanova A, Abate-Shen C.
Dutta A, et al.
Eur Urol. 2017 Oct;72(4):499-506. doi: 10.1016/j.eururo.2017.03.031. Epub 2017 Apr 4.
Eur Urol. 2017.
PMID: 28385453
Free PMC article.
Item in Clipboard
Cite
Cite